palbociclib,letrozole
pfizer
['paloma2', 'palbociclib', 'bcsm']
struggling palbociclib took another hit in #asco22 with the updated results from #paloma2 showing no benefit in os. but 30% of physicians choosing to stop a tx for a #bcsm patient who is responding is worrisome. 
Onc Fellow @uoaofficial Alexandra Hospital_ Proud Olympiacos Fan_Gifted underachiever